EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1249387, encodeId=9f7e124938e25, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：文章的创新点很明确的话，初审和审稿速度很快；我七月中旬投稿，八月底小修后，九月中旬接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958b6387686, createdName=ms3000000685476365, createdTime=Fri Sep 16 19:12:58 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099926, encodeId=481e20999260c, content=在杂志官网没找到投稿指南，只有投稿步骤说明，没有具体正文格式和字数要求，查阅往期杂志发现是结果和讨论一起的，请问大家这个有在哪里看到相关要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=897a2327846, createdName=122637e3m64(暂无昵称), createdTime=Fri Nov 11 16:33:36 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187510, encodeId=0c73118e51074, content=2022.1.15周六投稿现在with editor 不知道下周能不能送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c432501993, createdName=1249f369m71(暂无昵称), createdTime=Sun Jan 23 19:12:11 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857959, encodeId=a22c85e959db, content=审稿速度:3.0 经验分享：刚投出去，希望有好的结果吧。。。顺便问一下大家。。。with editor多长时间有可能送审... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Sun Mar 01 16:17:59 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075745, encodeId=52e710e574552, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药物化学 经验分享：请问投稿已经6个月了没有消息，5个月的时候问编辑说没有合适的审稿人，怎么办呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54326157570, createdName=ms5000001214242399, createdTime=Wed Dec 01 08:52:19 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066855, encodeId=8f1b10668559c, content=问一下拒稿时间多长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30055690743, createdName=ms7000000086424623, createdTime=Thu Nov 04 10:39:49 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055967, encodeId=a232105596e1b, content=有没有审完稿后收到邮件需要大修，但是邮件下面没有修改意见并且投稿系统里还显示Decision in process的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69d25172458, createdName=146dccabm30(暂无昵称), createdTime=Wed Sep 29 09:51:02 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861619, encodeId=75f3861619f0, content=审稿很快的， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5b85413973, createdName=ms7405767186922736, createdTime=Tue Jun 09 11:05:18 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858604, encodeId=1ea385860475, content=系统告知我已经找到了两个审稿人了，怎么还不开始审稿？焦急等待中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d44e5413969, createdName=ms4185585998171555, createdTime=Fri Mar 20 15:49:48 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858230, encodeId=226785823034, content=审稿速度:1.0 经验分享：中过三篇，药物化学，构效关系和药理研究三项要系统的研究才有机会接收。现在是一区了，难度比之前也加大了。药学领域仅次于jmc的杂志，很好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue Mar 10 04:38:52 CST 2020, time=2020-03-10, status=1, ipAttribution=)]

2022-09-16 ms3000000685476365

审稿速度:2.0 | 投稿命中率:25.0
经验分享：文章的创新点很明确的话，初审和审稿速度很快；我七月中旬投稿，八月底小修后，九月中旬接收

105 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1249387, encodeId=9f7e124938e25, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：文章的创新点很明确的话，初审和审稿速度很快；我七月中旬投稿，八月底小修后，九月中旬接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958b6387686, createdName=ms3000000685476365, createdTime=Fri Sep 16 19:12:58 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099926, encodeId=481e20999260c, content=在杂志官网没找到投稿指南，只有投稿步骤说明，没有具体正文格式和字数要求，查阅往期杂志发现是结果和讨论一起的，请问大家这个有在哪里看到相关要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=897a2327846, createdName=122637e3m64(暂无昵称), createdTime=Fri Nov 11 16:33:36 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187510, encodeId=0c73118e51074, content=2022.1.15周六投稿现在with editor 不知道下周能不能送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c432501993, createdName=1249f369m71(暂无昵称), createdTime=Sun Jan 23 19:12:11 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857959, encodeId=a22c85e959db, content=审稿速度:3.0 经验分享：刚投出去，希望有好的结果吧。。。顺便问一下大家。。。with editor多长时间有可能送审... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Sun Mar 01 16:17:59 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075745, encodeId=52e710e574552, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药物化学 经验分享：请问投稿已经6个月了没有消息，5个月的时候问编辑说没有合适的审稿人，怎么办呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54326157570, createdName=ms5000001214242399, createdTime=Wed Dec 01 08:52:19 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066855, encodeId=8f1b10668559c, content=问一下拒稿时间多长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30055690743, createdName=ms7000000086424623, createdTime=Thu Nov 04 10:39:49 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055967, encodeId=a232105596e1b, content=有没有审完稿后收到邮件需要大修，但是邮件下面没有修改意见并且投稿系统里还显示Decision in process的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69d25172458, createdName=146dccabm30(暂无昵称), createdTime=Wed Sep 29 09:51:02 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861619, encodeId=75f3861619f0, content=审稿很快的， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5b85413973, createdName=ms7405767186922736, createdTime=Tue Jun 09 11:05:18 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858604, encodeId=1ea385860475, content=系统告知我已经找到了两个审稿人了，怎么还不开始审稿？焦急等待中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d44e5413969, createdName=ms4185585998171555, createdTime=Fri Mar 20 15:49:48 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858230, encodeId=226785823034, content=审稿速度:1.0 经验分享：中过三篇，药物化学，构效关系和药理研究三项要系统的研究才有机会接收。现在是一区了，难度比之前也加大了。药学领域仅次于jmc的杂志，很好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue Mar 10 04:38:52 CST 2020, time=2020-03-10, status=1, ipAttribution=)]

2022-11-11 122637e3m64(暂无昵称)

在杂志官网没找到投稿指南，只有投稿步骤说明，没有具体正文格式和字数要求，查阅往期杂志发现是结果和讨论一起的，请问大家这个有在哪里看到相关要求吗？

105 0

[GetPortalCommentsPageByObjectIdResponse(id=1249387, encodeId=9f7e124938e25, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：文章的创新点很明确的话，初审和审稿速度很快；我七月中旬投稿，八月底小修后，九月中旬接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958b6387686, createdName=ms3000000685476365, createdTime=Fri Sep 16 19:12:58 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099926, encodeId=481e20999260c, content=在杂志官网没找到投稿指南，只有投稿步骤说明，没有具体正文格式和字数要求，查阅往期杂志发现是结果和讨论一起的，请问大家这个有在哪里看到相关要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=897a2327846, createdName=122637e3m64(暂无昵称), createdTime=Fri Nov 11 16:33:36 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187510, encodeId=0c73118e51074, content=2022.1.15周六投稿现在with editor 不知道下周能不能送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c432501993, createdName=1249f369m71(暂无昵称), createdTime=Sun Jan 23 19:12:11 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857959, encodeId=a22c85e959db, content=审稿速度:3.0 经验分享：刚投出去，希望有好的结果吧。。。顺便问一下大家。。。with editor多长时间有可能送审... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Sun Mar 01 16:17:59 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075745, encodeId=52e710e574552, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药物化学 经验分享：请问投稿已经6个月了没有消息，5个月的时候问编辑说没有合适的审稿人，怎么办呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54326157570, createdName=ms5000001214242399, createdTime=Wed Dec 01 08:52:19 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066855, encodeId=8f1b10668559c, content=问一下拒稿时间多长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30055690743, createdName=ms7000000086424623, createdTime=Thu Nov 04 10:39:49 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055967, encodeId=a232105596e1b, content=有没有审完稿后收到邮件需要大修，但是邮件下面没有修改意见并且投稿系统里还显示Decision in process的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69d25172458, createdName=146dccabm30(暂无昵称), createdTime=Wed Sep 29 09:51:02 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861619, encodeId=75f3861619f0, content=审稿很快的， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5b85413973, createdName=ms7405767186922736, createdTime=Tue Jun 09 11:05:18 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858604, encodeId=1ea385860475, content=系统告知我已经找到了两个审稿人了，怎么还不开始审稿？焦急等待中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d44e5413969, createdName=ms4185585998171555, createdTime=Fri Mar 20 15:49:48 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858230, encodeId=226785823034, content=审稿速度:1.0 经验分享：中过三篇，药物化学，构效关系和药理研究三项要系统的研究才有机会接收。现在是一区了，难度比之前也加大了。药学领域仅次于jmc的杂志，很好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue Mar 10 04:38:52 CST 2020, time=2020-03-10, status=1, ipAttribution=)]

2022-01-23 1249f369m71(暂无昵称)

2022.1.15周六投稿现在with editor 不知道下周能不能送审

114 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1249387, encodeId=9f7e124938e25, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：文章的创新点很明确的话，初审和审稿速度很快；我七月中旬投稿，八月底小修后，九月中旬接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958b6387686, createdName=ms3000000685476365, createdTime=Fri Sep 16 19:12:58 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099926, encodeId=481e20999260c, content=在杂志官网没找到投稿指南，只有投稿步骤说明，没有具体正文格式和字数要求，查阅往期杂志发现是结果和讨论一起的，请问大家这个有在哪里看到相关要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=897a2327846, createdName=122637e3m64(暂无昵称), createdTime=Fri Nov 11 16:33:36 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187510, encodeId=0c73118e51074, content=2022.1.15周六投稿现在with editor 不知道下周能不能送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c432501993, createdName=1249f369m71(暂无昵称), createdTime=Sun Jan 23 19:12:11 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857959, encodeId=a22c85e959db, content=审稿速度:3.0 经验分享：刚投出去，希望有好的结果吧。。。顺便问一下大家。。。with editor多长时间有可能送审... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Sun Mar 01 16:17:59 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075745, encodeId=52e710e574552, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药物化学 经验分享：请问投稿已经6个月了没有消息，5个月的时候问编辑说没有合适的审稿人，怎么办呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54326157570, createdName=ms5000001214242399, createdTime=Wed Dec 01 08:52:19 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066855, encodeId=8f1b10668559c, content=问一下拒稿时间多长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30055690743, createdName=ms7000000086424623, createdTime=Thu Nov 04 10:39:49 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055967, encodeId=a232105596e1b, content=有没有审完稿后收到邮件需要大修，但是邮件下面没有修改意见并且投稿系统里还显示Decision in process的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69d25172458, createdName=146dccabm30(暂无昵称), createdTime=Wed Sep 29 09:51:02 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861619, encodeId=75f3861619f0, content=审稿很快的， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5b85413973, createdName=ms7405767186922736, createdTime=Tue Jun 09 11:05:18 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858604, encodeId=1ea385860475, content=系统告知我已经找到了两个审稿人了，怎么还不开始审稿？焦急等待中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d44e5413969, createdName=ms4185585998171555, createdTime=Fri Mar 20 15:49:48 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858230, encodeId=226785823034, content=审稿速度:1.0 经验分享：中过三篇，药物化学，构效关系和药理研究三项要系统的研究才有机会接收。现在是一区了，难度比之前也加大了。药学领域仅次于jmc的杂志，很好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue Mar 10 04:38:52 CST 2020, time=2020-03-10, status=1, ipAttribution=)]

2020-03-01 ms8341280369405896

审稿速度:3.0
经验分享：刚投出去，希望有好的结果吧。。。顺便问一下大家。。。with editor多长时间有可能送审...

191 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1249387, encodeId=9f7e124938e25, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：文章的创新点很明确的话，初审和审稿速度很快；我七月中旬投稿，八月底小修后，九月中旬接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958b6387686, createdName=ms3000000685476365, createdTime=Fri Sep 16 19:12:58 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099926, encodeId=481e20999260c, content=在杂志官网没找到投稿指南，只有投稿步骤说明，没有具体正文格式和字数要求，查阅往期杂志发现是结果和讨论一起的，请问大家这个有在哪里看到相关要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=897a2327846, createdName=122637e3m64(暂无昵称), createdTime=Fri Nov 11 16:33:36 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187510, encodeId=0c73118e51074, content=2022.1.15周六投稿现在with editor 不知道下周能不能送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c432501993, createdName=1249f369m71(暂无昵称), createdTime=Sun Jan 23 19:12:11 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857959, encodeId=a22c85e959db, content=审稿速度:3.0 经验分享：刚投出去，希望有好的结果吧。。。顺便问一下大家。。。with editor多长时间有可能送审... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Sun Mar 01 16:17:59 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075745, encodeId=52e710e574552, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药物化学 经验分享：请问投稿已经6个月了没有消息，5个月的时候问编辑说没有合适的审稿人，怎么办呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54326157570, createdName=ms5000001214242399, createdTime=Wed Dec 01 08:52:19 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066855, encodeId=8f1b10668559c, content=问一下拒稿时间多长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30055690743, createdName=ms7000000086424623, createdTime=Thu Nov 04 10:39:49 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055967, encodeId=a232105596e1b, content=有没有审完稿后收到邮件需要大修，但是邮件下面没有修改意见并且投稿系统里还显示Decision in process的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69d25172458, createdName=146dccabm30(暂无昵称), createdTime=Wed Sep 29 09:51:02 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861619, encodeId=75f3861619f0, content=审稿很快的， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5b85413973, createdName=ms7405767186922736, createdTime=Tue Jun 09 11:05:18 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858604, encodeId=1ea385860475, content=系统告知我已经找到了两个审稿人了，怎么还不开始审稿？焦急等待中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d44e5413969, createdName=ms4185585998171555, createdTime=Fri Mar 20 15:49:48 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858230, encodeId=226785823034, content=审稿速度:1.0 经验分享：中过三篇，药物化学，构效关系和药理研究三项要系统的研究才有机会接收。现在是一区了，难度比之前也加大了。药学领域仅次于jmc的杂志，很好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue Mar 10 04:38:52 CST 2020, time=2020-03-10, status=1, ipAttribution=)]

2021-12-01 ms5000001214242399

审稿速度:12.0 | 投稿命中率:25.0
偏重的研究方向：药物化学
经验分享：请问投稿已经6个月了没有消息，5个月的时候问编辑说没有合适的审稿人，怎么办呢

126 0

[GetPortalCommentsPageByObjectIdResponse(id=1249387, encodeId=9f7e124938e25, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：文章的创新点很明确的话，初审和审稿速度很快；我七月中旬投稿，八月底小修后，九月中旬接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958b6387686, createdName=ms3000000685476365, createdTime=Fri Sep 16 19:12:58 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099926, encodeId=481e20999260c, content=在杂志官网没找到投稿指南，只有投稿步骤说明，没有具体正文格式和字数要求，查阅往期杂志发现是结果和讨论一起的，请问大家这个有在哪里看到相关要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=897a2327846, createdName=122637e3m64(暂无昵称), createdTime=Fri Nov 11 16:33:36 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187510, encodeId=0c73118e51074, content=2022.1.15周六投稿现在with editor 不知道下周能不能送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c432501993, createdName=1249f369m71(暂无昵称), createdTime=Sun Jan 23 19:12:11 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857959, encodeId=a22c85e959db, content=审稿速度:3.0 经验分享：刚投出去，希望有好的结果吧。。。顺便问一下大家。。。with editor多长时间有可能送审... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Sun Mar 01 16:17:59 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075745, encodeId=52e710e574552, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药物化学 经验分享：请问投稿已经6个月了没有消息，5个月的时候问编辑说没有合适的审稿人，怎么办呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54326157570, createdName=ms5000001214242399, createdTime=Wed Dec 01 08:52:19 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066855, encodeId=8f1b10668559c, content=问一下拒稿时间多长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30055690743, createdName=ms7000000086424623, createdTime=Thu Nov 04 10:39:49 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055967, encodeId=a232105596e1b, content=有没有审完稿后收到邮件需要大修，但是邮件下面没有修改意见并且投稿系统里还显示Decision in process的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69d25172458, createdName=146dccabm30(暂无昵称), createdTime=Wed Sep 29 09:51:02 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861619, encodeId=75f3861619f0, content=审稿很快的， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5b85413973, createdName=ms7405767186922736, createdTime=Tue Jun 09 11:05:18 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858604, encodeId=1ea385860475, content=系统告知我已经找到了两个审稿人了，怎么还不开始审稿？焦急等待中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d44e5413969, createdName=ms4185585998171555, createdTime=Fri Mar 20 15:49:48 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858230, encodeId=226785823034, content=审稿速度:1.0 经验分享：中过三篇，药物化学，构效关系和药理研究三项要系统的研究才有机会接收。现在是一区了，难度比之前也加大了。药学领域仅次于jmc的杂志，很好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue Mar 10 04:38:52 CST 2020, time=2020-03-10, status=1, ipAttribution=)]

2021-11-04 ms7000000086424623

问一下拒稿时间多长啊

130 0

[GetPortalCommentsPageByObjectIdResponse(id=1249387, encodeId=9f7e124938e25, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：文章的创新点很明确的话，初审和审稿速度很快；我七月中旬投稿，八月底小修后，九月中旬接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958b6387686, createdName=ms3000000685476365, createdTime=Fri Sep 16 19:12:58 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099926, encodeId=481e20999260c, content=在杂志官网没找到投稿指南，只有投稿步骤说明，没有具体正文格式和字数要求，查阅往期杂志发现是结果和讨论一起的，请问大家这个有在哪里看到相关要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=897a2327846, createdName=122637e3m64(暂无昵称), createdTime=Fri Nov 11 16:33:36 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187510, encodeId=0c73118e51074, content=2022.1.15周六投稿现在with editor 不知道下周能不能送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c432501993, createdName=1249f369m71(暂无昵称), createdTime=Sun Jan 23 19:12:11 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857959, encodeId=a22c85e959db, content=审稿速度:3.0 经验分享：刚投出去，希望有好的结果吧。。。顺便问一下大家。。。with editor多长时间有可能送审... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Sun Mar 01 16:17:59 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075745, encodeId=52e710e574552, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药物化学 经验分享：请问投稿已经6个月了没有消息，5个月的时候问编辑说没有合适的审稿人，怎么办呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54326157570, createdName=ms5000001214242399, createdTime=Wed Dec 01 08:52:19 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066855, encodeId=8f1b10668559c, content=问一下拒稿时间多长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30055690743, createdName=ms7000000086424623, createdTime=Thu Nov 04 10:39:49 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055967, encodeId=a232105596e1b, content=有没有审完稿后收到邮件需要大修，但是邮件下面没有修改意见并且投稿系统里还显示Decision in process的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69d25172458, createdName=146dccabm30(暂无昵称), createdTime=Wed Sep 29 09:51:02 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861619, encodeId=75f3861619f0, content=审稿很快的， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5b85413973, createdName=ms7405767186922736, createdTime=Tue Jun 09 11:05:18 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858604, encodeId=1ea385860475, content=系统告知我已经找到了两个审稿人了，怎么还不开始审稿？焦急等待中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d44e5413969, createdName=ms4185585998171555, createdTime=Fri Mar 20 15:49:48 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858230, encodeId=226785823034, content=审稿速度:1.0 经验分享：中过三篇，药物化学，构效关系和药理研究三项要系统的研究才有机会接收。现在是一区了，难度比之前也加大了。药学领域仅次于jmc的杂志，很好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue Mar 10 04:38:52 CST 2020, time=2020-03-10, status=1, ipAttribution=)]

2021-09-29 146dccabm30(暂无昵称)

有没有审完稿后收到邮件需要大修，但是邮件下面没有修改意见并且投稿系统里还显示Decision in process的？

124 0

[GetPortalCommentsPageByObjectIdResponse(id=1249387, encodeId=9f7e124938e25, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：文章的创新点很明确的话，初审和审稿速度很快；我七月中旬投稿，八月底小修后，九月中旬接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958b6387686, createdName=ms3000000685476365, createdTime=Fri Sep 16 19:12:58 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099926, encodeId=481e20999260c, content=在杂志官网没找到投稿指南，只有投稿步骤说明，没有具体正文格式和字数要求，查阅往期杂志发现是结果和讨论一起的，请问大家这个有在哪里看到相关要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=897a2327846, createdName=122637e3m64(暂无昵称), createdTime=Fri Nov 11 16:33:36 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187510, encodeId=0c73118e51074, content=2022.1.15周六投稿现在with editor 不知道下周能不能送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c432501993, createdName=1249f369m71(暂无昵称), createdTime=Sun Jan 23 19:12:11 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857959, encodeId=a22c85e959db, content=审稿速度:3.0 经验分享：刚投出去，希望有好的结果吧。。。顺便问一下大家。。。with editor多长时间有可能送审... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Sun Mar 01 16:17:59 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075745, encodeId=52e710e574552, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药物化学 经验分享：请问投稿已经6个月了没有消息，5个月的时候问编辑说没有合适的审稿人，怎么办呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54326157570, createdName=ms5000001214242399, createdTime=Wed Dec 01 08:52:19 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066855, encodeId=8f1b10668559c, content=问一下拒稿时间多长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30055690743, createdName=ms7000000086424623, createdTime=Thu Nov 04 10:39:49 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055967, encodeId=a232105596e1b, content=有没有审完稿后收到邮件需要大修，但是邮件下面没有修改意见并且投稿系统里还显示Decision in process的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69d25172458, createdName=146dccabm30(暂无昵称), createdTime=Wed Sep 29 09:51:02 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861619, encodeId=75f3861619f0, content=审稿很快的， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5b85413973, createdName=ms7405767186922736, createdTime=Tue Jun 09 11:05:18 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858604, encodeId=1ea385860475, content=系统告知我已经找到了两个审稿人了，怎么还不开始审稿？焦急等待中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d44e5413969, createdName=ms4185585998171555, createdTime=Fri Mar 20 15:49:48 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858230, encodeId=226785823034, content=审稿速度:1.0 经验分享：中过三篇，药物化学，构效关系和药理研究三项要系统的研究才有机会接收。现在是一区了，难度比之前也加大了。药学领域仅次于jmc的杂志，很好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue Mar 10 04:38:52 CST 2020, time=2020-03-10, status=1, ipAttribution=)]

2020-06-09 ms7405767186922736

审稿很快的，

216 0

[GetPortalCommentsPageByObjectIdResponse(id=1249387, encodeId=9f7e124938e25, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：文章的创新点很明确的话，初审和审稿速度很快；我七月中旬投稿，八月底小修后，九月中旬接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958b6387686, createdName=ms3000000685476365, createdTime=Fri Sep 16 19:12:58 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099926, encodeId=481e20999260c, content=在杂志官网没找到投稿指南，只有投稿步骤说明，没有具体正文格式和字数要求，查阅往期杂志发现是结果和讨论一起的，请问大家这个有在哪里看到相关要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=897a2327846, createdName=122637e3m64(暂无昵称), createdTime=Fri Nov 11 16:33:36 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187510, encodeId=0c73118e51074, content=2022.1.15周六投稿现在with editor 不知道下周能不能送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c432501993, createdName=1249f369m71(暂无昵称), createdTime=Sun Jan 23 19:12:11 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857959, encodeId=a22c85e959db, content=审稿速度:3.0 经验分享：刚投出去，希望有好的结果吧。。。顺便问一下大家。。。with editor多长时间有可能送审... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Sun Mar 01 16:17:59 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075745, encodeId=52e710e574552, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药物化学 经验分享：请问投稿已经6个月了没有消息，5个月的时候问编辑说没有合适的审稿人，怎么办呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54326157570, createdName=ms5000001214242399, createdTime=Wed Dec 01 08:52:19 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066855, encodeId=8f1b10668559c, content=问一下拒稿时间多长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30055690743, createdName=ms7000000086424623, createdTime=Thu Nov 04 10:39:49 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055967, encodeId=a232105596e1b, content=有没有审完稿后收到邮件需要大修，但是邮件下面没有修改意见并且投稿系统里还显示Decision in process的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69d25172458, createdName=146dccabm30(暂无昵称), createdTime=Wed Sep 29 09:51:02 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861619, encodeId=75f3861619f0, content=审稿很快的， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5b85413973, createdName=ms7405767186922736, createdTime=Tue Jun 09 11:05:18 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858604, encodeId=1ea385860475, content=系统告知我已经找到了两个审稿人了，怎么还不开始审稿？焦急等待中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d44e5413969, createdName=ms4185585998171555, createdTime=Fri Mar 20 15:49:48 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858230, encodeId=226785823034, content=审稿速度:1.0 经验分享：中过三篇，药物化学，构效关系和药理研究三项要系统的研究才有机会接收。现在是一区了，难度比之前也加大了。药学领域仅次于jmc的杂志，很好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue Mar 10 04:38:52 CST 2020, time=2020-03-10, status=1, ipAttribution=)]

2020-03-20 ms4185585998171555

系统告知我已经找到了两个审稿人了，怎么还不开始审稿？焦急等待中

240 0

[GetPortalCommentsPageByObjectIdResponse(id=1249387, encodeId=9f7e124938e25, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：文章的创新点很明确的话，初审和审稿速度很快；我七月中旬投稿，八月底小修后，九月中旬接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=958b6387686, createdName=ms3000000685476365, createdTime=Fri Sep 16 19:12:58 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099926, encodeId=481e20999260c, content=在杂志官网没找到投稿指南，只有投稿步骤说明，没有具体正文格式和字数要求，查阅往期杂志发现是结果和讨论一起的，请问大家这个有在哪里看到相关要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=897a2327846, createdName=122637e3m64(暂无昵称), createdTime=Fri Nov 11 16:33:36 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187510, encodeId=0c73118e51074, content=2022.1.15周六投稿现在with editor 不知道下周能不能送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c432501993, createdName=1249f369m71(暂无昵称), createdTime=Sun Jan 23 19:12:11 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857959, encodeId=a22c85e959db, content=审稿速度:3.0 经验分享：刚投出去，希望有好的结果吧。。。顺便问一下大家。。。with editor多长时间有可能送审... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69c95414119, createdName=ms8341280369405896, createdTime=Sun Mar 01 16:17:59 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075745, encodeId=52e710e574552, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药物化学 经验分享：请问投稿已经6个月了没有消息，5个月的时候问编辑说没有合适的审稿人，怎么办呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54326157570, createdName=ms5000001214242399, createdTime=Wed Dec 01 08:52:19 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066855, encodeId=8f1b10668559c, content=问一下拒稿时间多长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30055690743, createdName=ms7000000086424623, createdTime=Thu Nov 04 10:39:49 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055967, encodeId=a232105596e1b, content=有没有审完稿后收到邮件需要大修，但是邮件下面没有修改意见并且投稿系统里还显示Decision in process的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69d25172458, createdName=146dccabm30(暂无昵称), createdTime=Wed Sep 29 09:51:02 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861619, encodeId=75f3861619f0, content=审稿很快的， , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5b85413973, createdName=ms7405767186922736, createdTime=Tue Jun 09 11:05:18 CST 2020, time=2020-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858604, encodeId=1ea385860475, content=系统告知我已经找到了两个审稿人了，怎么还不开始审稿？焦急等待中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d44e5413969, createdName=ms4185585998171555, createdTime=Fri Mar 20 15:49:48 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858230, encodeId=226785823034, content=审稿速度:1.0 经验分享：中过三篇，药物化学，构效关系和药理研究三项要系统的研究才有机会接收。现在是一区了，难度比之前也加大了。药学领域仅次于jmc的杂志，很好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue Mar 10 04:38:52 CST 2020, time=2020-03-10, status=1, ipAttribution=)]

2020-03-10 ms2506877623970506

审稿速度:1.0
经验分享：中过三篇，药物化学，构效关系和药理研究三项要系统的研究才有机会接收。现在是一区了，难度比之前也加大了。药学领域仅次于jmc的杂志，很好。

0 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务